EE393 The Cost-Effectiveness of Atidarsagene Autotemcel (Arsa-Cel) for the Treatment of Metachromatic Leukodystrophy (MLD) in the US

Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.659
https://www.valueinhealthjournal.com/article/S1098-3015(23)03789-0/fulltext
Title : EE393 The Cost-Effectiveness of Atidarsagene Autotemcel (Arsa-Cel) for the Treatment of Metachromatic Leukodystrophy (MLD) in the US
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03789-0&doi=10.1016/j.jval.2023.09.659
First page :
Section Title :
Open access? : No
Section Order : 10145
Categories :
Tags :
Regions :
ViH Article Tags :